The time it takes to grow new skin for burns victims could be improved thanks to a new method of cell cultivation using algae ...

Methylation changes in microbiome-derived cfRNA enable more accurate CRC diagnosis than traditional DNA or abundance-based ...

As startups navigate the growing biotech sector in Wales, here are five biotech companies that are making waves in 2025.

Researchers found that clinically achievable doses of curcumin, the active compound in turmeric, target and suppress ...

In partnership with Syneos Health, the Company has engaged eight clinical sites and counting, and patient enrollment and processing efforts are underway. The lead principal investigator for the trial ...

Our objective was to culture these cells in order to understand them and exploit their therapeutic potential to the full. Design Here, hypothesising that some CTC potentially have cancer stem cell ...

The 2 cell lines were treated with appropriate concentrations of HDCA (0, 2.5, 5, 10, 25, 50, 100, 200, 400, and 800 μM) for 48 h in order to facilitate the selection of optimal treatment conditions.

The -SG diet inhibited the growth of CRC cells in culture. The anti-proliferative effect was coupled with a delay in entering the synthetic phase of the cell cycle.

CBX3 was identified as an antagonist of the IFNγ signaling cascade in the colon epithelium via repression of STAT1 and CD274 transcription. Upon IFNγ stimulation, CBX3 binding to STAT1 and CD274 ...

Cancerous cells synthesize most of their lipids de novo to keep up with their rapid growth and proliferation. Fatty acid synthase (FAS) is a key enzyme in the lipogenesis pathway that is upregulated ...

CellResearch Corporation, a Singapore-based biopharmaceutical company today announced it has successfully closed the first Phase I study in CorLiCyte®, a stem cell therapy derived from umbilical cord ...